Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Erkki Rintala"'
Autor:
Taina Isotalo, Kalmer Innos, Eero Kaasinen, Sirpa Aaltomaa, Erkki Rintala, Riikka Järvinen, Eija Kelloniemi, Pekka Hellström
Publikováno v:
In Vivo
Background/aim Non-muscle invasive bladder carcinoma (NMIBC) is highly recurrent. We studied if 5-aminolevulinic acid (5-ALA) instillations before transurethral resection of bladder tumours (TURBT) and cystoscopy extend the time to recurrence during
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3666a1081298d7931a7475e14612e194
https://doi.org/10.21873/invivo.12411
https://doi.org/10.21873/invivo.12411
Autor:
Mika Raitanen, Tapani Liukkonen, Erkki Rintala, Timo Marttila, Teuvo L.J. Tammela, Riikka Järvinen, Marjo Seppänen, Peter J. Boström, Pekka Hellström, Sirpa Aaltomaa, Markku J Leskinen, Eero Kaasinen
Publikováno v:
European Urology. 70:341-347
Background Patients with non–muscle-invasive bladder cancer (NMIBC) belonging to the intermediate-risk group should be treated with intravesical instillations to prevent recurrence and progression. Objective We compared the outcome of a monthly mai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48ccaa10a0868c7069e628098781d905
https://doi.org/10.1016/j.eururo.2016.03.034
https://doi.org/10.1016/j.eururo.2016.03.034
Autor:
Eero Kaasinen, Timo Marttila, Jukka Kallio, Jouko Viitanen, Markku H. Vaarala, Sirpa Aaltomaa, Kari Tuhkanen, Tapani Liukkonen, Veli-Matti Puolakka, Peter J. Boström, Riikka Järvinen, Erkki Rintala, Marjo Seppänen
Publikováno v:
European Urology. 68(4):611-617
Background Recurrent TaT1 non–muscle-invasive bladder cancer (NMIBC) patients should be treated with immediate instillation of chemotherapy after transurethral resection of bladder tumour followed by instillation therapy. Objective To present long-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3058a1637d9f245d586b5947904e42ea
https://doi.org/10.1016/j.eururo.2015.02.022
https://doi.org/10.1016/j.eururo.2015.02.022
Autor:
Hans Wijkström, Oddvar Mestad, Erkki Rintala, Staffan Jahnson, Per-Uno Malmström, Eero Kaasinen
Publikováno v:
Scandinavian journal of urology. 50(5)
The aim of this study was to compare the long-term efficacy of BCG monotherapy to alternating therapy of mitomycin C (MMC) and BCG in patients with carcinoma in situ (CIS).Between 1992 and 1997, 321 patients with CIS were randomized from Finland, Nor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1dcfe8f33388356422ce89be17c5cf0
https://pubmed.ncbi.nlm.nih.gov/27603425
https://pubmed.ncbi.nlm.nih.gov/27603425
Publikováno v:
Scandinavian Journal of Urology and Nephrology. 46:411-417
Only a few studies with a long-term follow-up exist on patients with carcinoma in situ (CIS) treated with instillation therapy. The objective was to study the long-term outcome of patients with CIS after mitomycin C (MMC) monotherapy or alternating t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbe962a475213316ce8af52bfda48971
https://doi.org/10.3109/00365599.2012.694906
https://doi.org/10.3109/00365599.2012.694906
Publikováno v:
European Urology. 56:260-265
Background The long-term prospective data on bacillus Calmette-Guerin (BCG) and mitomycin C (MMC) instillation therapy are limited. Objective To compare the long-term benefit of BCG and MMC maintenance therapy in patients with recurrent bladder carci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cec1b8d55d17e3ce7fdacbb706a7a59f
https://doi.org/10.1016/j.eururo.2009.04.009
https://doi.org/10.1016/j.eururo.2009.04.009
Autor:
Anna Sankila, Henrik Alfthan, Tanja Hakkarainen, Merja Särkioja, Martti Ala-Opas, Ulf-Håkan Stenman, Maria Rajecki, Akseli Hemminki, Erkki Rintala, Renee A. Desmond, Lotta Kangasniemi, Anna Kanerva, Mikko Tenhunen
Publikováno v:
Molecular Cancer Therapeutics. 6:742-751
Hormone refractory metastatic prostate cancer is a deadly disease that currently lacks curative treatments. Conditionally replicating adenoviruses (CRAds) are promising new agents against cancer due to their innate capability to cause oncolysis of tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a7285739008ef43d972e97c23e872c0
https://doi.org/10.1158/1535-7163.mct-06-0403
https://doi.org/10.1158/1535-7163.mct-06-0403
Autor:
Erkki Rintala, Kristina Hotakainen, Ulf-Håkan Stenman, Riikka Järvinen, Susanna Lintula, Annukka Paju, Jakob Stenman
Publikováno v:
Tumor Biology. 28:52-56
Human chorionic gonadotropin (hCG) is a marker of trophoblastic tumors, and the serum concentration of the free beta-subunit (hCGbeta) is an independent prognostic marker in several nontrophoblastic cancers. hCGbeta is encoded by six genes, of which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::461d065d96ebf4a34f0146b94ab11813
https://doi.org/10.1159/000097703
https://doi.org/10.1159/000097703
Publikováno v:
European urology. 68(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8fe1025f0eccfc0cfa9a254ceaaa86e2
https://pubmed.ncbi.nlm.nih.gov/25890484
https://pubmed.ncbi.nlm.nih.gov/25890484
Autor:
Staffan Jahnson, Miloš Duchek, Fredrik Wiklund, Sverker Hellsten, Erkki Rintala, Oddvar Mestad, Per-Uno Malmström
Publikováno v:
Scandinavian Journal of Urology and Nephrology. 39:206-210
Objective. To study residual tumours at second-look resection in patients resected 4-8 weeks earlier for T1 tumours of the urinary bladder. Material and methods. All patients randomized in the ongoing Nordic T1G2-G3 Bladder Sparing Study with monitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57cf33830df08919165597590b4379fa
https://doi.org/10.1080/00365590510007793-1
https://doi.org/10.1080/00365590510007793-1